COVID-19 continues to disrupt clinical trials
69.9 per cent of disruptions due to the suspension of enrolment, informs a GlobalData study
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
COVID-19
The new norm will be supply chain stress tests to build resilience
The COVID-19 crisis has thrown up unprecedented challenges and opportunities for the Indian pharma sector. Dr Arun Singh, Chief…
Working with India on COVID-19 vaccine development: US President
He also lauded Indian-Americans for their efforts in developing medicines and vaccines to treat the deadly coronavirus
COVID-19 clinical trials exhibit encouraging results: GlobalData
Four multinational clinical trials that are planning to enrol the most subjects are investigating remdesivir, sarilumab and…
RBI extension for IES export credit to benefit pharma MSMEs
RBI has extended IES export credit to March 31, 2021, and it is applicable on pre and post-shipment rupees export credit
Tech Mahindra leverages AI to research on potential therapeutic drugs for COVID-19
The company has conducted molecular docking studies of 19 FDA (Food and Drug Administration) approved ligands and anti-viral drugs
Takeda to go forward with annual performance appraisals, rewards
Koki Sato, GM, Takeda India indicates to Viveka Roychowdhury that in spite of the disruptions to the business cycle due to the…
Biocon registers a 42 per cent dip in profits for Q4
The company also reported a 15 per cent increase in EBITDA at Rs 1,765 Cr
World leaders unite for people’s vaccine against COVID-19
Call for guarantees that COVID-19 vaccines, diagnostics, tests and treatments will be provided free of charge to everyone,…
Hikal announces development of Favipiravir APIs and its intermediates
The company is in discussion with potential partners to supply the API and its intermediates